DK1049672T3 - Azetidincarboxamid-derivater til behandling af CNS-lidelser - Google Patents
Azetidincarboxamid-derivater til behandling af CNS-lidelserInfo
- Publication number
- DK1049672T3 DK1049672T3 DK99902658T DK99902658T DK1049672T3 DK 1049672 T3 DK1049672 T3 DK 1049672T3 DK 99902658 T DK99902658 T DK 99902658T DK 99902658 T DK99902658 T DK 99902658T DK 1049672 T3 DK1049672 T3 DK 1049672T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- cns disorders
- carboxamide derivatives
- azetidine carboxamide
- azetidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9801500.1A GB9801500D0 (en) | 1998-01-23 | 1998-01-23 | Chemical compounds - II |
GBGB9824457.7A GB9824457D0 (en) | 1998-11-06 | 1998-11-06 | Chemical compounds II |
PCT/GB1999/000219 WO1999037612A1 (en) | 1998-01-23 | 1999-01-22 | Azetidinecarboxamide derivatives for treating cns disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1049672T3 true DK1049672T3 (da) | 2004-01-19 |
Family
ID=26313010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99902658T DK1049672T3 (da) | 1998-01-23 | 1999-01-22 | Azetidincarboxamid-derivater til behandling af CNS-lidelser |
Country Status (10)
Country | Link |
---|---|
US (1) | US6403574B1 (da) |
EP (1) | EP1049672B1 (da) |
JP (1) | JP4542263B2 (da) |
AT (1) | ATE250027T1 (da) |
AU (1) | AU2287499A (da) |
DE (1) | DE69911373T2 (da) |
DK (1) | DK1049672T3 (da) |
ES (1) | ES2207171T3 (da) |
PT (1) | PT1049672E (da) |
WO (1) | WO1999037612A1 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9917386D0 (en) * | 1999-07-23 | 1999-09-22 | Cerebrus Ltd | Chemical compounds-II |
JP2006525298A (ja) * | 2003-05-01 | 2006-11-09 | ヴァーナリス リサーチ リミテッド | アゼチジンカルボキサミド誘導体及びcb1レセプター媒介障害の治療におけるその使用 |
KR20060017763A (ko) * | 2003-05-01 | 2006-02-27 | 베르날리스 리서치 리미티드 | 치료에 사용하는 아제티딘카르복스아미드 유도체의 용도 |
US20070173486A1 (en) * | 2003-05-01 | 2007-07-26 | Vernalis Research Limited | Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs |
US11141404B1 (en) | 2020-11-18 | 2021-10-12 | Anebulo Pharmaceuticals, Inc. | Formulations and methods for treating acute cannabinoid overdose |
WO2023064225A1 (en) | 2021-10-11 | 2023-04-20 | Anebulo Pharmaceuticals, Inc. | Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB872447A (en) * | 1958-12-23 | 1961-07-12 | Lepetit Spa | 1-carbamyl-3-substituted azetidines |
US4226861A (en) | 1978-04-18 | 1980-10-07 | A. H. Robins Company, Inc. | N-Lower-alkyl 3-phenoxy-1-azetidinecarboxamides |
IL68699A (en) * | 1982-08-19 | 1986-08-31 | Robins Co Inc A H | 3-phenoxy-1-azetidine-carboxamides,their preparation and pharmaceutical compositions containing them |
US4505907A (en) | 1982-09-02 | 1985-03-19 | A. H. Robins Company, Inc. | N-Formyl and N-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides |
US4956359A (en) * | 1985-02-28 | 1990-09-11 | A. H. Robins Company, Inc. | 3-aryloxy and 3-arylthioazetidinecarboxamides as anticonvulsants and antiepileptics |
FI87559C (fi) * | 1985-02-28 | 1993-01-25 | Robins Co Inc A H | Foerfarande foer framstaellning av aktiva 3-fenyloxiazetidinkarboxamider |
-
1999
- 1999-01-22 DK DK99902658T patent/DK1049672T3/da active
- 1999-01-22 ES ES99902658T patent/ES2207171T3/es not_active Expired - Lifetime
- 1999-01-22 EP EP99902658A patent/EP1049672B1/en not_active Expired - Lifetime
- 1999-01-22 DE DE69911373T patent/DE69911373T2/de not_active Expired - Lifetime
- 1999-01-22 AU AU22874/99A patent/AU2287499A/en not_active Abandoned
- 1999-01-22 JP JP2000528536A patent/JP4542263B2/ja not_active Expired - Lifetime
- 1999-01-22 AT AT99902658T patent/ATE250027T1/de not_active IP Right Cessation
- 1999-01-22 PT PT99902658T patent/PT1049672E/pt unknown
- 1999-01-22 US US09/600,628 patent/US6403574B1/en not_active Expired - Lifetime
- 1999-01-22 WO PCT/GB1999/000219 patent/WO1999037612A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
US6403574B1 (en) | 2002-06-11 |
AU2287499A (en) | 1999-08-09 |
WO1999037612A1 (en) | 1999-07-29 |
PT1049672E (pt) | 2004-02-27 |
EP1049672A1 (en) | 2000-11-08 |
EP1049672B1 (en) | 2003-09-17 |
DE69911373D1 (de) | 2003-10-23 |
JP4542263B2 (ja) | 2010-09-08 |
ATE250027T1 (de) | 2003-10-15 |
JP2002501045A (ja) | 2002-01-15 |
ES2207171T3 (es) | 2004-05-16 |
DE69911373T2 (de) | 2004-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY135841A (en) | Novel benzodioxoles | |
SG128491A1 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
FI931765A (fi) | Steroidderivat foer behandling av prostatahypertrofi, deras framstaellning och anvaendningar | |
JO2321B1 (en) | 4-phenyl-pyridine derivatives | |
ID26622A (id) | Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide | |
ATE272617T1 (de) | Sulfonamid-derivate | |
DK1049672T3 (da) | Azetidincarboxamid-derivater til behandling af CNS-lidelser | |
DK1049670T3 (da) | Azetidincarboxamidderivater til behandling af CNS-lidelser | |
SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
AP1396A (en) | 1-Trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives. | |
AU2178199A (en) | Azetidinecarboxamide derivatives for the treatment of cns disorders | |
AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
AU640590B2 (en) | 3-(1h-indazol-3-yl)-4-pyridinamines | |
YU79401A (sh) | Derivati 1-trifluorometil-4-hidroksi-7-piperidinil- aminometilhromana |